Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 587

1.

Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats.

Neckář J, Hye Khan MA, Gross GJ, Cyprová M, Hrdlička J, Kvasilová A, Falck JR, Campbell WB, Sedláková L, Škutová Š, Olejníčková V, Gregorovičová M, Sedmera D, Kolář F, Imig JD.

Clin Sci (Lond). 2019 Apr 12. pii: CS20180728. doi: 10.1042/CS20180728. [Epub ahead of print]

PMID:
30979784
2.

GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Park SK, Herrnreiter A, Pfister SL, Gauthier KM, Falck BA, Falck JR, Campbell WB.

J Biol Chem. 2018 Jul 6;293(27):10675-10691. doi: 10.1074/jbc.RA117.001297. Epub 2018 May 18.

PMID:
29777058
3.

Deactivation of 12(S)-HETE through (ω-1)-hydroxylation and β-oxidation in alternatively activated macrophages.

Kriska T, Thomas MJ, Falck JR, Campbell WB.

J Lipid Res. 2018 Apr;59(4):615-624. doi: 10.1194/jlr.M081448. Epub 2018 Feb 22.

4.

Effect of Angiotensin II and ACTH on Adrenal Blood Flow in the Male Rat Adrenal Gland In Vivo.

Shah AJ, Kriska T, Gauthier KM, Falck JR, Campbell WB.

Endocrinology. 2018 Jan 1;159(1):217-226. doi: 10.1210/en.2016-1594.

5.

Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries.

Kopf PG, Park SK, Herrnreiter A, Krause C, Roques BP, Campbell WB.

Endocrinology. 2018 Jan 1;159(1):238-247. doi: 10.1210/en.2017-00759.

6.

Orally Active Epoxyeicosatrienoic Acid Analogs.

Campbell WB, Imig JD, Schmitz JM, Falck JR.

J Cardiovasc Pharmacol. 2017 Oct;70(4):211-224. doi: 10.1097/FJC.0000000000000523. Review.

7.

Lowering Size Threshold for Elective Repair to Reduce Deaths from Abdominal Aortic Aneurysms - A Simple Solution to a Complex Problem?

Vallabhaneni SR, Campbell WB.

Eur J Vasc Endovasc Surg. 2017 Sep;54(3):275-277. doi: 10.1016/j.ejvs.2017.07.007. Epub 2017 Jul 26. No abstract available.

8.

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).

Wade J, Elliott D, Avery KNL, Gaunt D, Young GJ, Barnes R, Paramasivan S, Campbell WB, Blazeby JM, Birtle AJ, Stein RC, Beard DJ, Halliday AW, Donovan JL; ProtecT study group; CLASS study group; Chemorad study group; POUT study group; OPTIMA prelim study group; CSAW study group and ACST-2 study group.

Trials. 2017 Jul 17;18(1):327. doi: 10.1186/s13063-017-2048-7.

9.

Collecting data on treatments for varicose veins: Getting the focus right.

Campbell WB, Poole RL, Ray AF, Patrick HE.

Phlebology. 2017 May;32(4):224-226. doi: 10.1177/0268355516655247. Epub 2016 Jun 20. No abstract available.

PMID:
27329668
10.

Practical guide to the Idea, Development and Exploration stages of the IDEAL Framework and Recommendations.

Pennell CP, Hirst AD, Campbell WB, Sood A, Agha RA, Barkun JS, McCulloch P.

Br J Surg. 2016 Apr;103(5):607-15. doi: 10.1002/bjs.10115. Epub 2016 Feb 10.

PMID:
26865013
11.

Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.

Siangjong L, Goldman DH, Kriska T, Gauthier KM, Smyth EM, Puli N, Kumar G, Falck JR, Campbell WB.

Acta Physiol (Oxf). 2017 Jan;219(1):188-201. doi: 10.1111/apha.12642. Epub 2016 Jan 4.

12.

WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary Arteries.

Shah AJ, Gauthier KM, Imig JD, Falck JR, Campbell WB.

Value Health. 2014 Nov;17(7):A732-3. doi: 10.1016/j.jval.2014.08.091. Epub 2014 Oct 26. No abstract available.

13.

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury.

Khan AH, Falck JR, Manthati VL, Campbell WB, Imig JD.

Front Pharmacol. 2014 Sep 23;5:216. doi: 10.3389/fphar.2014.00216. eCollection 2014. Erratum in: Front Pharmacol. 2014;5:250.

14.

14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.

Falck JR, Koduru SR, Mohapatra S, Manne R, Atcha KR, Atcha R, Manthati VL, Capdevila JH, Christian S, Imig JD, Campbell WB.

J Med Chem. 2014 Aug 28;57(16):6965-72. doi: 10.1021/jm500262m. Epub 2014 Aug 19. Erratum in: J Med Chem. 2014 Nov 13;57(21):9218. Atcha, Krishnam Raju [added].

15.

A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol.

Nithipatikom K, Endsley MP, Pfeiffer AW, Falck JR, Campbell WB.

J Lipid Res. 2014 Oct;55(10):2093-102. doi: 10.1194/jlr.M051284. Epub 2014 Jun 23.

16.
17.

Survey of management of common iliac artery aneurysms by members of the Vascular Society of Great Britain and Ireland.

Williams SK, Campbell WB, Earnshaw JJ.

Ann R Coll Surg Engl. 2014 Mar;96(2):116-20. doi: 10.1308/003588414X13814021676512.

18.

Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.

Hye Khan MA, Pavlov TS, Christain SV, Neckář J, Staruschenko A, Gauthier KM, Capdevila JH, Falck JR, Campbell WB, Imig JD.

Clin Sci (Lond). 2014 Oct;127(7):463-74. doi: 10.1042/CS20130479.

19.

Aldosterone secretagogues increase adrenal blood flow in male rats.

Ansurudeen I, Kopf PG, Gauthier KM, Bornstein SR, Cowley AW Jr, Campbell WB.

Endocrinology. 2014 Jan;155(1):127-32. doi: 10.1210/en.2013-1532. Epub 2013 Dec 20.

20.

Role of macrophage PPARγ in experimental hypertension.

Kriska T, Cepura C, Gauthier KM, Campbell WB.

Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H26-32. doi: 10.1152/ajpheart.00287.2013. Epub 2013 Oct 25.

21.
22.

Strategies to reduce variation in the use of surgery.

McCulloch P, Nagendran M, Campbell WB, Price A, Jani A, Birkmeyer JD, Gray M.

Lancet. 2013 Sep 28;382(9898):1130-9. doi: 10.1016/S0140-6736(13)61216-7. Review.

PMID:
24075053
23.

Understanding of regional variation in the use of surgery.

Birkmeyer JD, Reames BN, McCulloch P, Carr AJ, Campbell WB, Wennberg JE.

Lancet. 2013 Sep 28;382(9898):1121-9. doi: 10.1016/S0140-6736(13)61215-5. Review.

24.

Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts.

Kriska T, Cepura C, Siangjong L, Wan TC, Auchampach JA, Shaish A, Haratz D, Kumar G, Falck JR, Gauthier KM, Campbell WB.

Prostaglandins Other Lipid Mediat. 2013 Oct;106:8-15. doi: 10.1016/j.prostaglandins.2013.07.002. Epub 2013 Jul 16.

25.

ACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries.

Gauthier KM, Cepura CJ, Campbell WB.

Biol Chem. 2013 Sep;394(9):1205-12. doi: 10.1515/hsz-2012-0348.

26.

Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2+ entry.

Zheng X, Zinkevich NS, Gebremedhin D, Gauthier KM, Nishijima Y, Fang J, Wilcox DA, Campbell WB, Gutterman DD, Zhang DX.

J Am Heart Assoc. 2013 Apr 25;2(3):e000080. doi: 10.1161/JAHA.113.000080.

27.

Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.

Ohta M, Toyama K, Gutterman DD, Campbell WB, Lemaître V, Teraoka R, Miura H.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):629-36. doi: 10.1161/ATVBAHA.112.300600. Epub 2013 Jan 3.

28.

Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Campbell WB, Gauthier KM.

J Cardiovasc Pharmacol. 2013 Mar;61(3):176-87. doi: 10.1097/FJC.0b013e31828165db. Review.

29.

Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line.

Oki K, Kopf PG, Campbell WB, Luis Lam M, Yamazaki T, Gomez-Sanchez CE, Gomez-Sanchez EP.

Endocrinology. 2013 Jan;154(1):214-21. doi: 10.1210/en.2012-1557. Epub 2012 Dec 7.

30.

Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.

Siangjong L, Gauthier KM, Pfister SL, Smyth EM, Campbell WB.

Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H382-92. doi: 10.1152/ajpheart.00690.2012. Epub 2012 Nov 30.

31.

Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.

Jennings BL, Estes AM, Anderson LJ, Fang XR, Yaghini FA, Fan Z, Gonzalez FJ, Campbell WB, Malik KU.

Hypertension. 2012 Dec;60(6):1510-6. doi: 10.1161/HYPERTENSIONAHA.112.202606. Epub 2012 Oct 29.

32.

Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension.

Kriska T, Cepura C, Magier D, Siangjong L, Gauthier KM, Campbell WB.

Am J Physiol Heart Circ Physiol. 2012 Jun 1;302(11):H2428-38. doi: 10.1152/ajpheart.01120.2011. Epub 2012 Mar 30.

33.

ROCK1 feedback regulation of the upstream small GTPase RhoA.

Tang AT, Campbell WB, Nithipatikom K.

Cell Signal. 2012 Jul;24(7):1375-80. doi: 10.1016/j.cellsig.2012.03.005. Epub 2012 Mar 11.

34.

11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.

Bukhari IA, Shah AJ, Gauthier KM, Walsh KA, Koduru SR, Imig JD, Falck JR, Campbell WB.

Am J Physiol Heart Circ Physiol. 2012 Apr 15;302(8):H1574-83. doi: 10.1152/ajpheart.01122.2011. Epub 2012 Feb 3.

35.

Diversity and distribution of Odonata (Insecta) larvae along an altitudinal gradient in Coalcomán mountains, Michoacán, Mexico.

Gómez-Anaya JA, Novelo-Gutiérrez R, Campbell WB.

Rev Biol Trop. 2011 Dec;59(4):1559-77.

PMID:
22208074
36.

Endothelial nitric oxide and 15-lipoxygenase-1 metabolites independently mediate relaxation of the rabbit aorta.

Aggarwal NT, Gauthier KM, Campbell WB.

Vascul Pharmacol. 2012 Jan-Feb;56(1-2):106-12. doi: 10.1016/j.vph.2011.12.002. Epub 2011 Dec 16.

37.

Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.

Jennings BL, Anderson LJ, Estes AM, Yaghini FA, Fang XR, Porter J, Gonzalez FJ, Campbell WB, Malik KU.

Hypertension. 2012 Feb;59(2):348-54. doi: 10.1161/HYPERTENSIONAHA.111.183301. Epub 2011 Dec 19.

38.

Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.

Jennings BL, Anderson LJ, Estes AM, Fang XR, Song CY, Campbell WB, Malik KU.

Am J Physiol Renal Physiol. 2012 Feb 15;302(4):F408-20. doi: 10.1152/ajprenal.00542.2011. Epub 2011 Nov 16.

39.

Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.

Nithipatikom K, Gomez-Granados AD, Tang AT, Pfeiffer AW, Williams CL, Campbell WB.

Endocrinology. 2012 Jan;153(1):29-41. doi: 10.1210/en.2011-1144. Epub 2011 Nov 15. Erratum in: Endocrinology. 2012 May;153(5):2531.

40.

Eicosanoids and disease. Introduction.

Spector AA, Campbell WB, Zeldin DC.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):1-2. doi: 10.1016/j.prostaglandins.2011.10.001. Epub 2011 Oct 8. No abstract available.

PMID:
22004919
41.

Prophylaxis of venous thromboembolism in general surgery: guidelines differ and we still need local policies.

Veeramootoo D, Harrower L, Saunders R, Robinson D, Campbell WB.

Ann R Coll Surg Engl. 2011 Jul;93(5):370-4. doi: 10.1308/003588411X580926.

42.

Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.

Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Falck JR, Campbell WB.

Am J Physiol Renal Physiol. 2011 Oct;301(4):F765-72. doi: 10.1152/ajprenal.00201.2011. Epub 2011 Jul 13.

43.

20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor.

Chen Y, Falck JR, Manthati VL, Jat JL, Campbell WB.

Biochemistry. 2011 May 10;50(18):3840-8. doi: 10.1021/bi102070w. Epub 2011 Apr 15.

44.

Role of superoxide and thromboxane receptors in acute angiotensin II-induced vasoconstriction of rabbit vessels.

Pfister SL, Nithipatikom K, Campbell WB.

Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2064-71. doi: 10.1152/ajpheart.01135.2010. Epub 2011 Apr 1.

45.

Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.

Kopf PG, Gauthier KM, Zhang DX, Falck JR, Campbell WB.

Hypertension. 2011 Feb;57(2):323-9. doi: 10.1161/HYPERTENSIONAHA.110.158311. Epub 2011 Jan 3.

46.

Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries.

Gauthier KM, Goldman DH, Aggarwal NT, Chawengsub Y, Falck JR, Campbell WB.

Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H725-35. doi: 10.1152/ajpheart.00696.2009. Epub 2010 Dec 30.

47.

Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Nithipatikom K, Isbell MA, Endsley MP, Woodliff JE, Campbell WB.

Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):34-43. doi: 10.1016/j.prostaglandins.2010.12.002. Epub 2010 Dec 15.

48.

Vascular pharmacology of epoxyeicosatrienoic acids.

Pfister SL, Gauthier KM, Campbell WB.

Adv Pharmacol. 2010;60:27-59. doi: 10.1016/B978-0-12-385061-4.00002-7. Review.

49.

14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.

Bukhari IA, Gauthier KM, Jagadeesh SG, Sangras B, Falck JR, Campbell WB.

J Pharmacol Exp Ther. 2011 Jan;336(1):47-55. doi: 10.1124/jpet.110.169797. Epub 2010 Sep 29.

50.

Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.

Nithipatikom K, Brody DM, Tang AT, Manthati VL, Falck JR, Williams CL, Campbell WB.

Cancer Sci. 2010 Dec;101(12):2629-36. doi: 10.1111/j.1349-7006.2010.01713.x. Epub 2010 Aug 27.

Supplemental Content

Loading ...
Support Center